Amedisys Stock Today
| AMED Stock | USD 91.16 0.08 0.09% |
Performance0 of 100
| Odds Of DistressLess than 14
|
Amedisys is trading at 91.16 as of the 23rd of April 2024, a -0.09 percent down since the beginning of the trading day. The stock's lowest day price was 91.13. Amedisys has less than a 14 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Amedisys are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of February 2024 and ending today, the 23rd of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 17th of August 1994 | Category Healthcare | Classification Health Care |
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana. Amedisys operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. The company has 32.67 M outstanding shares of which 2.49 M shares are presently shorted by private and institutional investors with about 7.11 trading days to cover. More on Amedisys
Moving together with Amedisys Stock
| 0.76 | DH | Definitive Healthcare Financial Report 2nd of May 2024 | PairCorr |
| 0.84 | GH | Guardant Health Financial Report 14th of May 2024 | PairCorr |
| 0.76 | FIGS | Figs Inc Financial Report 2nd of May 2024 | PairCorr |
Moving against Amedisys Stock
| 0.81 | GCTK | GlucoTrack | PairCorr |
| 0.74 | WGS | GeneDx Holdings Corp Earnings Call This Week | PairCorr |
| 0.52 | RCM | R1 RCM Inc Financial Report 2nd of May 2024 | PairCorr |
| 0.47 | HQY | HealthEquity Financial Report 3rd of June 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 1st of May 2024
Amedisys Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Amedisys' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Amedisys or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO President | Richard Ashworth | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Name | Amedeo Resources Plc | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, SP Midcap 400, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Health Care Providers & Services, Medical Care Facilities, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Amedisys report their recommendations after researching Amedisys' financial statements, talking to executives and customers, or listening in on Amedisys' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Amedisys. The Amedisys consensus assessment is calculated by taking the average forecast from all of the analysts covering Amedisys. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Amedisys' liquidity, profitability, solvency, and operating efficiency, Amedisys may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of Amedisys is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amedisys' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Amedisys' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Amedisys' financial leverage. It provides some insight into what part of Amedisys' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amedisys (AMED) is traded on NASDAQ Exchange in USA. It is located in 3854 American Way, Baton Rouge, LA, United States, 70816 and employs 19,000 people. Amedisys is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.98 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Amedisys's market, we take the total number of its shares issued and multiply it by Amedisys's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Amedisys conducts business under Health Care Providers & Services sector and is part of Health Care industry. The entity has 32.67 M outstanding shares of which 2.49 M shares are presently shorted by private and institutional investors with about 7.11 trading days to cover.
Amedisys currently holds about 17.96 M in cash with 137.19 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.55.
Check Amedisys Probability Of Bankruptcy
Ownership AllocationAmedisys holds a total of 32.67 Million outstanding shares. The majority of Amedisys outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Amedisys to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Amedisys. Please pay attention to any change in the institutional holdings of Amedisys as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Amedisys Ownership Details
Amedisys Stock Price Odds Analysis
What are Amedisys' target price odds to finish over the current price? Based on a normal probability distribution, the odds of Amedisys jumping above the current price in 90 days from now is roughly 97.0%. The Amedisys probability density function shows the probability of Amedisys stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Amedisys has a beta of 0.2011. This suggests as returns on the market go up, Amedisys average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Amedisys will be expected to be much smaller as well. Additionally, amedisys has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Amedisys to move above the current price in 90 days from now is roughly 97.0 (This Amedisys probability density function shows the probability of Amedisys Stock to fall within a particular range of prices over 90 days) .
Amedisys Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Amedisys that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Amedisys' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Amedisys' value.| Instituion | Recorded On | Shares | |
| Melqart Asset Management (uk) Ltd. | 2023-12-31 | 653.8 K | |
| Magnetar Financial Llc | 2023-12-31 | 618.9 K | |
| Alliancebernstein L.p. | 2023-12-31 | 545.1 K | |
| Geode Capital Management, Llc | 2023-12-31 | 527.5 K | |
| Dimensional Fund Advisors, Inc. | 2023-12-31 | 511.6 K | |
| Cresset Asset Management, Llc | 2023-12-31 | 454.4 K | |
| Van Lanschot Kempen Investment Management Nv | 2023-12-31 | 451.2 K | |
| Woodline Partners Lp | 2023-12-31 | 446.7 K | |
| Marshall Wace Asset Management Ltd | 2023-12-31 | 406.6 K | |
| Vanguard Group Inc | 2023-12-31 | 3.2 M | |
| Blackrock Inc | 2023-12-31 | 3 M |
Amedisys Historical Income Statement
Amedisys Income Statement is one of the three primary financial statements used for reporting Amedisys's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Amedisys revenue and expense. Amedisys Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Amedisys' Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 2.3 B, whereas Gross Profit is forecasted to decline to about 447.4 M. View More FundamentalsAmedisys Stock Against Markets
Picking the right benchmark for Amedisys stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Amedisys stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Amedisys is critical whether you are bullish or bearish towards Amedisys at a given time. Please also check how Amedisys' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Amedisys without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
| All Next | Launch Module |
Amedisys Corporate Directors
Amedisys corporate directors refer to members of an Amedisys board of directors. The board of directors generally takes responsibility for the Amedisys' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Amedisys' board members must vote for the resolution. The Amedisys board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Jeffrey Rideout | Director | Profile | |
| Nathaniel Zilkha | Director | Profile | |
| Bruce Perkins | Independent Director | Profile | |
| Linda Hall | Independent Director | Profile |
How to buy Amedisys Stock?
Before investing in Amedisys, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Amedisys. To buy Amedisys stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Amedisys. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Amedisys stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Amedisys stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Amedisys stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Amedisys, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Amedisys Stock please use our How to Invest in Amedisys guide.
Already Invested in Amedisys?
The danger of trading Amedisys is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Amedisys is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Amedisys. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Amedisys is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Amedisys is a strong investment it is important to analyze Amedisys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amedisys' future performance. For an informed investment choice regarding Amedisys Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amedisys. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.Note that the Amedisys information on this page should be used as a complementary analysis to other Amedisys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Amedisys Stock analysis
When running Amedisys' price analysis, check to measure Amedisys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amedisys is operating at the current time. Most of Amedisys' value examination focuses on studying past and present price action to predict the probability of Amedisys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amedisys' price. Additionally, you may evaluate how the addition of Amedisys to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Amedisys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.40) | Earnings Share (0.30) | Revenue Per Share 68.603 | Quarterly Revenue Growth 0.016 | Return On Assets 0.0598 |
The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.